Children born with HIV or born exposed to HIV face unique challenges during childhood and as they reach adolescence and young adulthood - and they may also have unique resilience. Improvements in treatment options for HIV have made earlier and more comprehensive treatment of perinatal HIV infection possible.
Our SMARTT and AMP Up Series studies have made significant advances in understanding the long-term physical, mental, and behavioral impact of HIV infection and its treatment on the maturation process in these children.
In 2020, PHACS was awarded renewed funding as a Program Project, supporting our multidisciplinary, long-term research program to further investigate the safety of early antiretroviral and HIV exposure as our participants continue to age into adulthood. Both SMARTT and the AMP Up Series will continue with renewed scope, along with a new protocol investigating the long-term neurological impacts of early ARV and HIV exposures, TERBO BRAIN.
To request a copy of any protocol, please email us.